Your browser doesn't support javascript.
loading
ProCAID: a phase I clinical trial to combine the AKT inhibitor AZD5363 with docetaxel and prednisolone chemotherapy for metastatic castration resistant prostate cancer.
Crabb, Simon J; Birtle, Alison J; Martin, Karen; Downs, Nichola; Ratcliffe, Ian; Maishman, Tom; Ellis, Mary; Griffiths, Gareth; Thompson, Stuart; Ksiazek, Lidia; Khoo, Vincent; Jones, Robert J.
Afiliação
  • Crabb SJ; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK. S.J.Crabb@southampton.ac.uk.
  • Birtle AJ; Lancashire Teaching Hospitals NHS Foundation Trust, Preston, UK.
  • Martin K; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Downs N; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Ratcliffe I; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Maishman T; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Ellis M; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Griffiths G; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Thompson S; Southampton Clinical Trials Unit, University of Southampton, Southampton, UK.
  • Ksiazek L; Patient and Public Involvement Representative, Southampton, UK.
  • Khoo V; Southampton Experimental Cancer Medicine Centre, University of Southampton, Southampton, UK.
  • Jones RJ; The Royal Marsden NHS Foundation Trust, London, UK.
Invest New Drugs ; 35(5): 599-607, 2017 10.
Article em En | MEDLINE | ID: mdl-28144789

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Próstata Resistentes à Castração Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2017 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Protocolos de Quimioterapia Combinada Antineoplásica / Proteínas Proto-Oncogênicas c-akt / Neoplasias de Próstata Resistentes à Castração Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Invest New Drugs Ano de publicação: 2017 Tipo de documento: Article